Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | NAAA | Q02083 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MITF | O75030 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.33 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3937425 | 0.95 | HTT (0.34) | HTTSMN1; SMN2NPC1GAAEPHX1 | |
| SCHEMBL295003 | 0.91 | TSHR (0.36) | HTTSMN1; SMN2NPC1GAATP53 | |
| Maleic Acid SCHEMBL27868428 | 0.84 | HTT (0.40) | HTTSMN1; SMN2NPC1GAAEPHX1 | |
| SCHEMBL1412758 | 0.78 | EPHX1 (0.40) | HTTSMN1; SMN2EPHX1CYP2C19NAAA | |
| SCHEMBL4156013 | 0.77 | ATM (0.47) | HTTSMN1; SMN2NPC1GAAEPHX1 | |
| SCHEMBL4156019 | 0.77 | ATM (0.47) | HTTSMN1; SMN2NPC1GAAEPHX1 | |
| Cyclohexyl Fumarate SCHEMBL528629 | 0.77 | ATM (0.47) | HTTSMN1; SMN2NPC1GAAEPHX1 | |
| SCHEMBL4158798 | 0.77 | ATM (0.47) | HTTSMN1; SMN2NPC1GAAEPHX1 | |
| Cyclohexyl Fumarate SCHEMBL528630 | 0.77 | ATM (0.47) | HTTSMN1; SMN2NPC1GAAEPHX1 | |
| Fumaric Acid SCHEMBL7564862 | 0.77 | ATM (0.47) | HTTSMN1; SMN2NPC1GAAEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070166269-A1 | Cosmetic composition containing a statistical polymer with a linear chain of ethylenic nature | L'OREAL (FR) | 2007-07-19 | — | — | US | claimed |
| US-20070092473-A1 | Cosmetic composition containing a statistical polymer with a linear main chain of ethylenic nature | L'OREAL (FR) | 2007-04-26 | — | — | US | claimed |
| WO-2019028248-A1 | SYSTEMS AND METHODS FOR IMPROVING DELIVERY OF TOPICAL ACTIVES | YOUNG PHARMACEUTICALS, INC. (US) | 2019-02-07 | — | — | WO | disclosed |
| US-20100203004-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | L'OREAL (FR) | 2010-08-12 | — | — | US | disclosed |
| EP-2205197-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | L'Oreal (FR) | 2010-07-14 | — | — | EP | disclosed |
| US-20100009931-A1 | ASSOCIATION OF A TENSOR AGENT OR DEVICE AND A SACCHARIDE COMPOUND | L'OREAL (FR) | 2010-01-14 | — | — | US | disclosed |
| US-20090285770-A1 | Topical Compositions for Promoting Homeostasis of the Skin | L'OREAL (FR) | 2009-11-19 | — | — | US | disclosed |
| WO-2009056545-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | L'OREAL (FR) | 2009-05-07 | — | — | WO | disclosed |
| US-20080305069-A1 | Cosmetic Use of Tensing Agents to Improve the Thickness of the Skin and/or the Radiance of the Complexion | L'OREAL (FR) | 2008-12-11 | — | — | US | disclosed |
| EP-1951191-A1 | TOPICAL COMPOSITIONS FOR PROMOTING HOMEOSTASIS OF THE SKIN | L'Oréal (FR) | 2008-08-06 | — | — | EP | disclosed |
| EP-1951378-A1 | COSMETIC USE OF TENSING AGENTS TO IMPROVE THE THICKNESS OF THE SKIN AND/OR THE RADIANCE OF THE COMPLEXION | L'Oréal (FR) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007057452-A1 | COSMETIC USE OF TENSING AGENTS TO IMPROVE THE HOMEOSTASIS OF THE SKIN AND/OR THE RADIANCE OF THE COMPLEXION | L'ORÉAL (FR) | 2007-05-24 | — | — | WO | disclosed |
| WO-2007057448-A1 | TOPICAL COMPOSITIONS FOR PROMOTING HOMEOSTASIS OF THE SKIN | L'ORÉAL (FR) | 2007-05-24 | — | — | WO | disclosed |
| US-20070092473-A1 | Cosmetic composition containing a statistical polymer with a linear main chain of ethylenic nature | L'OREAL (FR) | 2007-04-26 | — | — | US | disclosed |
| EP-1441911-A2 | MICROCAPSULES HAVING IMPROVED PRINTING AND EFFICIENCY | Appleton Papers Inc. (US) | 2004-08-04 | — | — | EP | disclosed |
| WO-2003031192-A2 | MICROCAPSULES HAVING IMPROVED PRINTING AND EFFICIENCY | APPLETON PAPERS INC. (US) | 2003-04-17 | — | — | WO | disclosed |
| US-6544926-B1 | Pressure sensitive copying material | APPLETON PAPERS INC. | 2003-04-08 | — | — | US | disclosed |
| EP-0133352-B1 | A PROCESS FOR MANUFACTURING MICROCAPSULES | APPLETON PAPERS INC. (US) | 1987-05-06 | — | — | EP | disclosed |
| US-4552811-A | AMINO RESIN, ACRYLIC ACID-ALKYL ACRYLATE COPOLYMER | APPLETON PAPERS INC. (US) | 1985-11-12 | — | — | US | disclosed |
| EP-0133352-A2 | A process for manufacturing microcapsules | APPLETON PAPERS INC. (US) | 1985-02-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070166269-A1 | Cosmetic composition containing a statistical polymer with a linear chain of ethylenic nature | POLH, LAGE3, ELOVL6 | HTT 91/4885SMN1; SMN2 2923/4885NPC1 2788/4885 |
| US-20090285770-A1 | Topical Compositions for Promoting Homeostasis of the Skin | CUTA, PIEZO1, TSLP | HTT 3779/4885SMN1; SMN2 772/4885NPC1 2422/4885 |
| US-20100009931-A1 | ASSOCIATION OF A TENSOR AGENT OR DEVICE AND A SACCHARIDE COMPOUND | PIEZO1, TRPA1, TREH | HTT 2481/4885SMN1; SMN2 1106/4885NPC1 3303/4885 |
| US-20100203004-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | PHOSPHO1, CUTA, SGMS1 | HTT 3357/4885SMN1; SMN2 3042/4885NPC1 4308/4885 |
| US-20070092473-A1 | Cosmetic composition containing a statistical polymer with a linear main chain of ethylenic nature | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, TELO2, METTL14 | HTT 241/4885SMN1; SMN2 2991/4885NPC1 2723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.